3978. Deputy Louis O'Hara asked the Minister for Health whether her Department is considering reimbursing the cost of GLP-1 drugs for preventative uses such as in cases where a person is pre-diabetic or suffers from other medical conditions such as polyendocrine metabolic ovarian syndrome and a medical professional has advised that the use of these drugs is clinically appropriate. [63875/26]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.